Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7303 p730
12 June 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
The Medicines (Advertising) Amendment Regulations 2004 (more)


OTC advertising restrictions removed

Rules that prevent the advertising of over-the-counter medicines for 13 conditions are to be scrapped on 30 June.

“Removing these restrictions on promoting non-prescription medicines to the public has the potential to bring real public health benefits by giving more power and information to patients,” the Medicines and Healthcare products Regulatory Agency said.

The change will make it possible to advertise Zocor Heart Pro (simvastatin) when it is launched as a pharmacy medicine later this year.

The announcement, which has been welcomed by the Proprietary Association of Great Britain, follows a consultation process launched at the end of 2002 (PJ, 9 November 2002, p665)

There will be no change to the ban on advertising prescription medicines to the public.
A European prohibition on the public advertising of medicines for a range of serious conditions is to be removed next year.

Back to Top


©The Pharmaceutical Journal